QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.54 (-0.82%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.32 (+0.28%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.54 (-0.82%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.32 (+0.28%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.54 (-0.82%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.32 (+0.28%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.43 (-6.06%)
AMD   176.54 (-0.82%)
BABA   74.59 (-3.98%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   4.99 (+3.74%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.32 (+0.28%)

C4 Therapeutics (CCCC) Short Interest Ratio & Short Volume

$10.95
+1.20 (+12.31%)
(As of 05:12 PM ET)

C4 Therapeutics Short Interest Data

Current Short Volume
3,180,000 shares
Previous Short Volume
3,350,000 shares
Change Vs. Previous Month
-5.07%
Dollar Volume Sold Short
$25.12 million
Short Interest Ratio / Days to Cover
0.2
Last Record Date
February 15, 2024
Outstanding Shares
49,280,000 shares
Percentage of Shares Shorted
6.45%
Today's Trading Volume
5,677,482 shares
Average Trading Volume
5,173,910 shares
Today's Volume Vs. Average
110%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling C4 Therapeutics ?

Sign up to receive the latest short interest report for C4 Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CCCC Short Interest Over Time

CCCC Days to Cover Over Time

CCCC Percentage of Float Shorted Over Time


C4 Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/20243,180,000 shares $25.12 million -5.1%N/A0.2 $7.90
1/31/20243,350,000 shares $20.70 million -39.6%8.7%0.2 $6.18
1/15/20245,550,000 shares $37.74 million +22.3%14.5%0.4 $6.80
12/31/20234,540,000 shares $25.65 million -44.0%10.8%0.3 $5.65
12/15/20238,100,000 shares $40.10 million +330.9%19.3%0.7 $4.95
11/30/20231,880,000 shares $3.06 million -3.6%4.5%3.4 $1.63
11/15/20231,950,000 shares $3.51 million +2.1%4.7%4.1 $1.80
10/31/20231,910,000 shares $2.85 million +4.4%4.6%3.9 $1.49
10/15/20231,830,000 shares $3.64 million -19.0%4.6%3.8 $1.99
9/30/20232,260,000 shares $4.20 million -5.0%5.6%5.2 $1.86
9/15/20232,380,000 shares $5.31 million +14.4%5.9%2.4 $2.23
8/31/20232,080,000 shares $6.03 million +9.5%5.2%1.9 $2.90
8/15/20231,900,000 shares $6.42 million -10.0%4.7%1.6 $3.38
7/31/20232,110,000 shares $8.21 million -5.8%5.3%1.7 $3.89
7/15/20232,240,000 shares $7.50 million -8.9%5.6%1.8 $3.35
6/30/20232,460,000 shares $6.77 million -26.4%6.1%2 $2.75
6/15/20233,340,000 shares $12.06 million +2.8%8.3%5.1 $3.61
5/31/20233,250,000 shares $11.02 million +12.1%8.1%5.4 $3.39
5/15/20232,900,000 shares $9.69 million +0.7%7.2%5.2 $3.34
4/30/20232,880,000 shares $8.70 million +1.8%7.0%5 $3.02
4/15/20232,830,000 shares $9.48 million +7.6%6.9%4.9 $3.35
3/31/20232,630,000 shares $8.26 million -9.9%6.5%4.5 $3.14
3/15/20232,920,000 shares $12.59 million -10.2%7.2%5.1 $4.31
2/28/20233,250,000 shares $17.13 million +0.9%8.0%6.3 $5.27
2/15/20233,220,000 shares $18.58 million -12.5%7.9%6.1 $5.77
1/31/20233,680,000 shares $28.67 million +2.8%9.0%7 $7.79
1/15/20233,580,000 shares $30.57 million +2.0%8.8%7.8 $8.54
12/30/20223,510,000 shares $20.71 million -3.6%8.6%7.8 $5.90
12/15/20223,640,000 shares $29.48 million +0.3%8.9%8 $8.10
11/30/20223,630,000 shares $31.11 million -8.1%8.9%7.5 $8.57
11/15/20223,950,000 shares $38.39 million -19.1%9.7%8.5 $9.72
10/31/20224,880,000 shares $46.95 million -1.2%11.9%11.4 $9.62
10/15/20224,940,000 shares $39.32 million -2.0%12.9%12.1 $7.96
9/30/20225,040,000 shares $44.20 million +11.0%13.2%11.9 $8.77
9/15/20224,540,000 shares $51.57 million -6.8%11.8%9.8 $11.36
8/31/20224,870,000 shares $49.09 million -5.1%12.7%9.9 $10.08
8/15/20225,130,000 shares $62.23 million -3.2%13.4%9.2 $12.13
7/31/20225,300,000 shares $51.09 million +1.5%13.9%8.2 $9.64
7/15/20225,220,000 shares $52.30 million +2.8%13.7%7.2 $10.02
6/30/20225,080,000 shares $38.30 million +20.7%13.3%4.7 $7.54













CCCC Short Interest - Frequently Asked Questions

What is C4 Therapeutics' current short interest?

Short interest is the volume of C4 Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 3,180,000 shares of CCCC short. Learn More on C4 Therapeutics' current short interest.

Which institutional investors are shorting C4 Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of C4 Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is C4 Therapeutics' short interest increasing or decreasing?

C4 Therapeutics saw a decrease in short interest in February. As of February 15th, there was short interest totaling 3,180,000 shares, a decrease of 5.1% from the previous total of 3,350,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does C4 Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to C4 Therapeutics: Invivyd, Inc. (5.99%), Humacyte, Inc. (8.76%), Valneva SE (0.01%), Anavex Life Sciences Corp. (24.22%), Lexeo Therapeutics, Inc. (2.81%), Replimune Group, Inc. (13.94%), Tenaya Therapeutics, Inc. (4.07%), Voyager Therapeutics, Inc. (5.91%), Harpoon Therapeutics, Inc. (11.72%), Nurix Therapeutics, Inc. (14.87%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short C4 Therapeutics stock?

Short selling CCCC is an investing strategy that aims to generate trading profit from C4 Therapeutics as its price is falling. CCCC shares are trading up $1.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against C4 Therapeutics?

A short squeeze for C4 Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CCCC, which in turn drives the price of the stock up even further.

How often is C4 Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CCCC, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CCCC) was last updated on 2/28/2024 by MarketBeat.com Staff